Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Leases (2016 - 2025)

Pharma-Bio Serv filings provide 12 years of Leases readings, the most recent being $29388.0 for Q4 2025.

  • On a quarterly basis, Leases fell 85.2% to $29388.0 in Q4 2025 year-over-year; TTM through Oct 2025 was $29388.0, a 85.2% decrease, with the full-year FY2025 number at $29388.0, down 85.2% from a year prior.
  • Leases hit $29388.0 in Q4 2025 for Pharma-Bio Serv, down from $72747.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $790561.0 in Q1 2021 to a low of $29388.0 in Q4 2025.
  • Median Leases over the past 5 years was $412419.0 (2023), compared with a mean of $409359.8.
  • Biggest five-year swings in Leases: dropped 12.97% in 2021 and later tumbled 85.2% in 2025.
  • Pharma-Bio Serv's Leases stood at $639969.0 in 2021, then dropped by 21.45% to $502685.0 in 2022, then fell by 29.09% to $356450.0 in 2023, then crashed by 44.28% to $198597.0 in 2024, then tumbled by 85.2% to $29388.0 in 2025.
  • The last three reported values for Leases were $29388.0 (Q4 2025), $72747.0 (Q3 2025), and $115259.0 (Q2 2025) per Business Quant data.